The chart below shows how BG performed 10 days before and after its earnings report, based on data from the past quarters. Typically, BG sees a +1.34% change in stock price 10 days leading up to the earnings, and a -0.12% change 10 days following the report. On the earnings day itself, the stock moves by -0.90%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Earnings Per Share Increase: Reported fourth-quarter earnings per share was $4.36 compared to $4.18 in the fourth quarter of 2023, reflecting a year-over-year increase.
Adjusted EBIT Performance: Adjusted core segment earnings before interest and taxes (EBIT) was $548 million in the quarter, including a $52 million recovery from Ukraine business interruption insurance.
Strong Cash Generation: For the full year, Bunge generated approximately $1.7 billion of adjusted funds from operations, demonstrating strong cash generation capabilities.
Capital Expenditures Overview: Total capital expenditures for the year were approximately $1.4 billion, aligning with forecasts and supporting ongoing growth initiatives.
Strong Liquidity Position: At year-end, Bunge had a cash balance of $3.3 billion and unused committed credit facilities of $8.7 billion, indicating strong liquidity and financial stability.
Negative
Earnings Per Share Decline: Bunge Limited reported an adjusted EPS of $2.13 for Q4 2024, significantly lower than the $3.70 reported in Q4 2023, indicating a decline of 42.3%.
Q4 EBIT Decline: Core segment EBIT for Q4 2024 was $548 million, down from $881 million in the same quarter last year, reflecting a decrease of 37.7% due to challenging market conditions in South America.
North America Performance Decline: The company experienced lower results in North America attributed to a balanced supply and demand environment and uncertainty regarding U.S. biofuel policy, negatively impacting margins.
EPS Decline Projection: Full-year adjusted EPS for 2025 is projected to be approximately $7.75, which is a decline from previous expectations, reflecting ongoing challenges in the agribusiness sector.
Capital Expenditure Reduction: Capital expenditures for 2025 are expected to be in the range of $1.5 billion to $1.7 billion, down from the preliminary estimate of $1.9 billion to $2 billion, indicating a reduction in growth investment plans.
Bunge Limited (NYSE:BG) Q4 2024 Earnings Call Transcript
BG.N
-1.36%